See also this year's filing and all EDGAR filings for this company.
PDF Report 0001396814_2021_Pacira_Biosciences_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 429647000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 4331.264, 'aggregate_val': 541533000, 'exp_sum': 125000, 'exp_to_value': {'remainder_Revenues': 125000}} |
Graph
Absolute values for 0001396814, Pacira Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 651,623,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 196,068,000 |
| 2 | PropertyPlantAndEquipmentNet | 136,688,000 |
| 3 | remainder_Assets | 290,134,000 |
| 4 | LiabilitiesCurrent | 253,328,000 |
| 5 | LiabilitiesNoncurrent | 74,857,000 |
| 6 | remainder_Liabilities | 326,640,000 |
| 7 | CostOfGoodsAndServicesSold | 128,829,064 |
| 8 | SellingGeneralAndAdministrativeExpense | 191,663,118 |
| 9 | ResearchAndDevelopmentExpense | 54,485,102 |
| 10 | remainder_Expenses | 31,148,302 |
| 11 | remainder_Revenues | 433,670,197 |
| 12 | remainder_NetIncome | -33,024,658 |
| 13 | remainder_ComprehensiveNetIncome | 345,865 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,274,513,000 |
| 1 | Liabilities | 654,825,000 |
| 2 | Expenses | 406,125,586 |
| 3 | Revenues | 433,670,197 |
| 4 | StockholdersEquity | 619,688,000 |
| 5 | NetIncome | -5,480,047 |
| 6 | ComprehensiveNetIncome | -5,307,114 |
| 7 | BaseVar | 1,401,252,153 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.39 |
| 9 | EconomicCapitalRatio | 2.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
